Submit an Article
Online ISSN: 1945-4589
Impact Journals, LLC. is the publisher of Aging: www.impactjournals.com.
Impact Journals is a member of the Wellcome Trust List of Compliant Publishers.
Impact Journals is a member of the Society for Scholarly Publishing.
Learn about our FREE Post-Publication Promotion Services
Editorial Volume 10, Issue 11 pp 3042—3043

IDOL in metabolic, neurodegenerative and cardiovascular disease

Nienke M. van Loon1, , Patrick C.N. Rensen2, , Noam Zelcer1, ,

  • 1 Department of Medical Biochemistry, Academic Medical Center, University of Amsterdam, 1105AZ Amsterdam, The Netherlands
  • 2 Department of Medicine, Division of Endocrinology and Einthoven Laboratory for Experimental Vascular and Regenerative Medicine, Leiden University Medical Center, 2333ZA Leiden, the Netherlands

Received: September 27, 2018       Published: October 14, 2018      

https://doi.org/10.18632/aging.101597
How to Cite

Copyright: © 2018 van Loon et al. This is an open access article distributed under the terms of the Creative Commons Attribution License (CC BY 3.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.

Download PDF
Corresponding Author

Noam Zelcer
n.zelcer@amc.uva.nl

Keywords
cholesterol lipoprotein receptors E3 ubiquitin ligase metabolic syndrome Alzheimer’s disease